Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Antimicrobial Chemotherapy
|
April 1, 1990
Antimicrobial therapy and temperature
J W Van Esser, A W Sturm
The Netherlands Journal of Medicine
|
July 1, 1995
An uncommon cause of anaemia in ulcerative colitis
J W van Esser, L P Bos, F L Erdkamp
Clinical Nephrology
|
November 1, 1992
The effects of recombinant human erythropoietin on hemostasis and fibrinolysis in hemodialysis patients
J J Wirtz, J W van Esser, K Hamulyák, et al.
Bone Marrow Transplantation
|
June 18, 1999
Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation
A P Gadisseur, J W Gratama, C Lamers, et al.
Blood
|
August 25, 2001
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection
J W Gratama, J W van Esser, C H Lamers, et al.
The European Respiratory Journal
|
April 1, 1995
A young woman with cough and chest pain
J W van Esser, A F van Belle, R J Lamers, et al.
Blood Purification
|
January 1, 1990
Recombinant human erythropoietin and its effects on macro- and microcirculation during normovolemia. A physiological study of hemodynamics, fluid status and skin microcirculation
J J Wirtz, K M Leunissen, J W van Esser, et al.
Blood
|
March 25, 2000
Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation
A E Broers, R van Der Holt, J W van Esser, et al.
Blood
|
August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT
J W van Esser, B van der Holt, E Meijer, et al.
British Journal of Haematology
|
June 19, 2001
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation
J W van Esser, H G Niesters, S F Thijsen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Antimicrobial Chemotherapy
|
April 1, 1990
Antimicrobial therapy and temperature
J W Van Esser, A W Sturm
The Netherlands Journal of Medicine
|
July 1, 1995
An uncommon cause of anaemia in ulcerative colitis
J W van Esser, L P Bos, F L Erdkamp
Clinical Nephrology
|
November 1, 1992
The effects of recombinant human erythropoietin on hemostasis and fibrinolysis in hemodialysis patients
J J Wirtz, J W van Esser, K Hamulyák, et al.
Bone Marrow Transplantation
|
June 18, 1999
Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation
A P Gadisseur, J W Gratama, C Lamers, et al.
Blood
|
August 25, 2001
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection
J W Gratama, J W van Esser, C H Lamers, et al.
The European Respiratory Journal
|
April 1, 1995
A young woman with cough and chest pain
J W van Esser, A F van Belle, R J Lamers, et al.
Blood Purification
|
January 1, 1990
Recombinant human erythropoietin and its effects on macro- and microcirculation during normovolemia. A physiological study of hemodynamics, fluid status and skin microcirculation
J J Wirtz, K M Leunissen, J W van Esser, et al.
Blood
|
March 25, 2000
Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation
A E Broers, R van Der Holt, J W van Esser, et al.
Blood
|
August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT
J W van Esser, B van der Holt, E Meijer, et al.
British Journal of Haematology
|
June 19, 2001
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation
J W van Esser, H G Niesters, S F Thijsen, et al.
Page
of 1